Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin Experience
Christopher S. Stauffer, B. Anderson, Kile Ortigo, et al.
ACS Pharmacology & Translational Science (2020) Vol. 4, Iss. 2, pp. 526-532
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects
Jacob S. Aday, Alan K. Davis, Cayla M. Mitzkovitz, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 2, pp. 424-435
Open Access | Times Cited: 167
Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression
Roberta Murphy, Hannes Kettner, Rick Zeifman, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 140
Psychedelics and Other Psychoplastogens for Treating Mental Illness
Maxemiliano V. Vargas, Retsina Meyer, Arabo A. Avanes, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 113
The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world
Rosalind Watts, Hannes Kettner, Dana Geerts, et al.
Psychopharmacology (2022) Vol. 239, Iss. 11, pp. 3461-3483
Open Access | Times Cited: 83
Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis
Yuan Yao, Dan Guo, Tangsheng Lu, et al.
Psychiatry Research (2024) Vol. 335, pp. 115886-115886
Closed Access | Times Cited: 24
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder
Adam W. Levin, Rafael Lancelotta, Nathan D. Sepeda, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0300501-e0300501
Open Access | Times Cited: 23
Psychedelic-Assisted Psychotherapy—A Systematic Review of Associated Psychological Interventions
Mauro Cavarra, Alessandra Falzone, Johannes G. Ramaekers, et al.
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 67
Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample
Victoria Amalie Nygart, Lis Marie Pommerencke, Eline Haijen, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 8, pp. 932-942
Open Access | Times Cited: 48
Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective
John R. Kelly, Claire M. Gillan, Jack Prenderville, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 50
Prevalence and therapeutic impact of adverse life event reexperiencing under ceremonial ayahuasca
Brandon Weiss, Aleksandra Wingert, David Erritzøe, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 21
Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis.
Gabrielle Agin-Liebes, Elizabeth M. Nielson, Michael A. Zingman, et al.
Psychology of Addictive Behaviors (2023) Vol. 38, Iss. 1, pp. 101-113
Closed Access | Times Cited: 18
Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences
Richard J. Zeifman, Hannes Kettner, Broc A. Pagni, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Psychedelics and sexual functioning: a mixed-methods study
Tommaso Barba, Hannes Kettner, Caterina Radu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Participant Reports of Mindfulness, Posttraumatic Growth, and Social Connectedness in Psilocybin-Assisted Group Therapy: An Interpretive Phenomenological Analysis
Gabrielle Agin-Liebes, Eve Ekman, B. Anderson, et al.
Journal of Humanistic Psychology (2021) Vol. 64, Iss. 4, pp. 564-591
Closed Access | Times Cited: 33
Psilocybin for Trauma-Related Disorders
Amanda Khan, Ellen R. Bradley, Aoife O’Donovan, et al.
Current topics in behavioral neurosciences (2022), pp. 319-332
Closed Access | Times Cited: 23
Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors
Polina Ponomarenko, Federico Seragnoli, Abigail E. Calder, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 660-678
Open Access | Times Cited: 15
A rapid narrative review of the clinical evolution of psychedelic treatment in clinical trials
Ronit Kishon, Nadav Liam Modlin, Yael M. Cycowicz, et al.
npj Mental Health Research (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 4
Shame, Guilt and Psychedelic Experience: Results from a Prospective, Longitudinal Survey of Real-World Psilocybin Use
David S. Mathai, Daniel E. Roberts, Sandeep M. Nayak, et al.
Journal of Psychoactive Drugs (2025), pp. 1-12
Open Access
Psychedelics and Pro-Social Behaviors: A Perspective on Autism Spectrum Disorders
Xue Wang, Cong Lin, Xiaohui Wang
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 3, pp. 903-906
Closed Access
Exploring Serotonergic Psychedelics as a Treatment for Personality Disorders
Brennan M. Carrithers, Daniel E. Roberts, Brandon Weiss, et al.
Neuropharmacology (2025), pp. 110413-110413
Closed Access
Exploring the potential of psychedelic-assisted psychotherapy for moral injury: A scoping review
Viktoriia Kurkova, Olga Winkler, Andrew J. Greenshaw, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111333-111333
Closed Access
Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey
Joanna Kuc, Hannes Kettner, Fernando E. Rosas, et al.
Psychopharmacology (2021) Vol. 239, Iss. 5, pp. 1425-1440
Open Access | Times Cited: 29
Predictors of Psychedelic Experience: A Thematic Analysis
Annie M. McCartney, H. T. McGovern, Alexander De Foe
Journal of Psychoactive Drugs (2022) Vol. 55, Iss. 4, pp. 411-419
Open Access | Times Cited: 19
A perspective-based analysis of attachment from prenatal period to second year postnatal life
Erica Santaguida, Massîmo Bergamasco
Frontiers in Psychology (2024) Vol. 15
Open Access | Times Cited: 3
Body mass index (BMI) does not predict responses to psilocybin
Meg J. Spriggs, Bruna Giribaldi, Taylor Lyons, et al.
Journal of Psychopharmacology (2022) Vol. 37, Iss. 1, pp. 107-116
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top